SHANNON DIEHL: Open Payments
NPI 1740568062 · MONROE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$648 in 27 payments from 18 companies in 2025. Trend: 2023 $55 · 2024 $238 · 2025 $648
Food & beverage: $648
| Company | Payments | Amount |
|---|---|---|
| Sequel Med Tech, LLC | 2 | $50 |
| Lilly USA, LLC | 2 | $50 |
| Xeris Pharmaceuticals, Inc. | 2 | $49 |
| ABBVIE INC. | 2 | $48 |
| Insulet Corporation | 2 | $47 |
| Novo Nordisk Inc | 2 | $46 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $45 |
| SANOFI-AVENTIS U.S. LLC | 1 | $45 |
| Tandem Diabetes Care, Inc. | 2 | $44 |
| Ascendis Pharma Endocrinology Inc | 2 | $41 |
Products named: TWIIST, MOUNJARO, RECORLEV, SYNTHROID, Omnipod, Kerendia, TZIELD, t:slim X2 Insulin Pump with Control-IQ.
Industry payments across NY — which companies pay providers there.
